to 20 days has been suggested as more sensitive than Hb A1,, for assessing short-term glycemic control [2, 3] .
This study investigated analytical performance of the fructosamine assay with the BM/Hitachi 747-200 Automatic Analyzer. We used a second-generation fructosamine assay [4] , which is a modification of the method described by Johnson et al. [5] , and evaluated possible interference with the fructosamine assay by lipemia, hyperbilirubinemia, and hemolysis. We investigated the correlation between fructosamine and other measures of diabetic control, particularly Hb A1 and fasting glucose. 
Matenals and Methods

REAGENTS
STATISTICAL ANALYSES
The significance of differences in the two categories (normal and increased triglyceride samples) was determined by Student's t-test. Correlations were analyzed by linear regression.
Results
Precision (within-run
CVs and total imprecision CVs) and bias are shown in Table 1 . Linearity was established up to 1000 .tmoVL (r = 1.00; slope = 0.99) (Fig. 1) .
The fructosamine assay showed no discernible change from lipemia (because a triglyceride concentration of up to 28.25 mmol/L in the specimens caused the final results to be within ±3% of the original value) (Fig. 2A) . No change in results occurred at Hb up to 15.5 .tmol/LHb, but positive interference (an increase of 10% from the original value) occurred between 15.5 and 77.5 .tmol/L Hb (Fig. 2B) (Fig. 2C) . Fructosamine concentration increased -0.9% for each 10 mol/L increase in bilirubin concentration.
Mean fructosamine concentration in serum from 100 nondiabetic subjects and 100 diabetic subjects is shown in Intralipid(g/L) Ratio of serum volume to total volume Fig. 1 . Relation between fructosamine result and dilution (with 9 g/L NaCI) of artificially produced high-fructosamine serum.
+, mean of two measurements at each concentration; r = 1.00.
with increased triglyceride concentration in either nondiabetic or diabetic subjects (P >0.05).
The reference intervals were established by using fasting samples from 228 nondiabetic physical examination outpatients with fasting glucose concentration <5.0 mmol/L. These data were normally distributed.
The reference interval (mean value ± 2SD, 242 /.Lmol/L ± 40) for fructosarnine was 202-282 zmol/L (n = 228); the reference interval for fructosamine corrected for albumin was 191-265 .tmol/L (mean value 228 mol/L) (Fig.  3) . Albumin values in diabetic patients were 3 3-49 g/L (mean ± 2SD = 41 ± 8, n = 440); in nondiabetic patients, albumin values were 35-52 g/L (43 ± 3, n = 228). Hemolyzed and icteric sera were excluded.
Correlations between fructosamine concentration, Hb A, concentration, and fasting glucose concentration are shown in Table 3 . Uncorrected, total-protein-corrected, and albumincorrected fructosamine showed statistically significantly higher correlation with fasting glucose concentrations than I-lb A1 did (P <0.001).
Discussion
Results in this study were similar to the manufacturer's published values [within-run CVs: 1.5% (low concentration), 0.9% (mid concentration), 0.7% (high concentration); total imprecision CVs: 1.8% (low concentration), 1.7% (mid concentration), 1.5% (high concentration)].
This study verified that the fructosamine assay done with the BM/Hitachi 747-200 Automatic Analyzer had acceptable imprecision (<2%) for use in the clinical laboratory.
Its linearity of up to 1000 .tmol/L, which was roughly 3.5 times the upper reference limit, was sufficient to cover the pathological range of diabetic patients in poor metabolic control (in this study, the highest fructosamine concentration in patients with poorly controlled diabetes was 938 jimol/L).
Regarding the effects of hypertriglyceridemia on fructosamine concentration, 
Interferent; lipid (A), Hb (B), bilirubin (C).
fructosamine assay. Our study found that measured serum fructosamine concentration was free from interference from 
